Key publications

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Sep 2015 in The Lancet Respiratory Medicine, vol. 3, pp. 684-691
DOI: https://doi.org/10.1016/S2213-2600(15)00245-3
Research output: Contribution to Journal › Article (Published)

Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial
(8 pages) 12 Sep 2015 in The Lancet, vol. 386, pp. 1041-1048
DOI: https://doi.org/10.1016/S0140-6736(15)00163-4
Research output: Contribution to Journal › Article (Published)

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
(9 pages) 1 Feb 2016 in The Lancet Respiratory Medicine, vol. 4, pp. 107-115
DOI: https://doi.org/10.1016/S2213-2600(15)00545-7
Research output: Contribution to Journal › Article (Published)

International management platform for children's interstitial lung disease (chILD-EU)
3 Nov 2017 in Thorax
DOI: https://doi.org/10.1136/thoraxjnl-2017-210519
Research output: Contribution to Journal › Article (Published)

Supine posture changes lung volumes and increases ventilation heterogeneity in cystic fibrosis
27 Nov 2017 in PLoS ONE, vol. 12, pp. e0188275
DOI: https://doi.org/10.1371/journal.pone.0188275
Research output: Contribution to Journal › Article (Published)

View all 96 publications on Research Explorer

Data last updated: 16/09/2021 at 11:54